ISO 14971

ISO 14791 Definition

What is the ISO 14971 standard?

ISO 14971 is an international standard that establishes a risk management framework for medical devices. It defines a structured method for assessing and controlling risks linked to medical devices. This method applies from the initial design phase through production, post-market monitoring, and final disposal.

The standard emphasizes a proactive and continuous risk management process, requiring manufacturers to:

  • Identify potential hazards related to medical device use.
  • Estimate and evaluate associated risks.
  • Implement risk control measures to mitigate hazards.
  • Assess the effectiveness of risk controls.
  • Monitor risks throughout the product lifecycle, including post-market surveillance.

ISO14971 Frequently Asked Questions:

What is the difference between ISO 14971 and ISO 13485?

ISO 14971 and ISO 13485 are both critical standards in the medical device industry, but they serve different purposes.

 

  • ISO 14971 outlines a structured approach to risk management for medical devices. This standard applies throughout the product lifecycle to ensure safety and compliance. It guides manufacturers in establishing a systematic approach to risk assessment, ensuring that potential hazards are mitigated to protect patient and user safety.

 

  • ISO 13485 is a quality management system (QMS) standard that establishes requirements for organizations working with medical devices. It covers design, development, production, and servicing. It focuses on regulatory compliance, process control, and documentation to ensure product consistency and quality.

 

Although ISO 14971 is a standalone risk management standard, it’s closely linked to ISO 13485. That standard requires medical device manufacturers to incorporate risk-based decision-making into their quality management processes. This approach aligns with the principles ISO 14971 outlines. Many organizations incorporate ISO 14971 into their ISO 13485-compliant QMS to enhance risk management. This integration helps maintain overall regulatory compliance.

What are the major changes in ISO 14971?

The most recent version, ISO 14971:2019, introduced key updates, including:

 

  • Stronger emphasis on risk-benefit analysis.

 

  • Clarifications on risk management throughout the product lifecycle.

 

  • Additional guidance on production and post-production activities.

 

  • Enhanced alignment with regulatory expectations from authorities like the FDA and EU MDR.

What is the difference between ISO 14971 and FMEA?

ISO 14971 and Failure Modes and Effects Analysis (FMEA) are both essential for managing risk in medical device development. However, they differ in scope and application.

 

  • ISO 14971 defines a structured risk management approach for medical devices. It guides manufacturers in identifying, assessing, controlling, and monitoring risks across the product lifecycle. This standard addresses every stage of risk management, from hazard identification and risk estimation to control measures, residual risk evaluation, and post-market surveillance.

 

  • FMEA is a risk assessment tool used within the broader ISO 14971 framework. It first identifies potential failure modes in a product, process, or system. Then, it evaluates their root causes, possible effects, and necessary measures to mitigate risks. FMEA is widely used to identify design or process weaknesses and proactively improve reliability.

 

FMEA is often used within an ISO 14971 risk management system as a risk assessment tool for specific product components or processes. While FMEA focuses on identifying and ranking failure modes, ISO 14971 takes a broader approach. It includes factors such as risk acceptability, risk-benefit analysis, and risk controls beyond failure mode analysis.

Get in Touch for an EQMS Demo

Take a minute
to learn more about ETQ Reliance EQMS